Assignee
INTERMUNE INC
US·40 granted patents·65 pending applications·517 citations·filing 1983–2019
Top patents by PatentIndex Score
105 records- 0198US7491794B2Macrocyclic compounds as inhibitors of viral replicationINTERMUNE INC·Filed 2005·Granted Feb 17, 2009·147 cites·1 claims
- 0296US7816383B1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2010·Granted Oct 19, 2010·27 cites·20 claims
- 0396US7728013B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2006·Granted Jun 1, 2010·40 cites·19 claims
- 0496US7696236B2Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2009·Granted Apr 13, 2010·32 cites·7 claims
- 0595US7767700B2Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2007·Granted Aug 3, 2010·26 cites·19 claims
- 0694US7566729B1Modifying pirfenidone treatment for patients with atypical liver functionINTERMUNE INC·Filed 2009·Granted Jul 28, 2009·37 cites·9 claims
- 0793US7829665B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2006·Granted Nov 9, 2010·27 cites·29 claims
- 0893US7635707B1Pirfenidone treatment for patients with atypical liver functionINTERMUNE INC·Filed 2009·Granted Dec 22, 2009·15 cites·14 claims
- 0991US8013002B2Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2011·Granted Sep 6, 2011·9 cites·11 claims
- 1091US7910610B1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2010·Granted Mar 22, 2011·10 cites·11 claims
- 1190US9675593B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2016·Granted Jun 13, 2017·10 cites·24 claims
- 1290US7767225B2Capsule formulation of pirfenidone and pharmaceutically acceptable excipientsINTERMUNE INC·Filed 2009·Granted Aug 3, 2010·11 cites·20 claims
- 1389US9359379B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2013·Granted Jun 7, 2016·12 cites·21 claims
- 1489US8383150B2Granulate formulation of pirfenidone and pharmaceutically acceptable excipientsINTERMUNE INC·Filed 2011·Granted Feb 26, 2013·9 cites·27 claims
- 1589US7988994B2Capsule formulation of pirfenidone and pharmaceutically acceptable excipientsINTERMUNE INC·Filed 2006·Granted Aug 2, 2011·10 cites·28 claims
- 1688US8969347B2Compounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2012·Granted Mar 3, 2015·10 cites·22 claims
- 1788US7407973B2Use of pirfenidone in therapeutic regimensINTERMUNE INC·Filed 2004·Granted Aug 5, 2008·36 cites·18 claims
- 1887US7638488B2Use of alpha-glucosidase inhibitors to treat alphavirus infectionsINTERMUNE INC·Filed 2006·Granted Dec 29, 2009·3 cites·20 claims
- 1986US10376497B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2017·Granted Aug 13, 2019·5 cites·37 claims
- 2085US8778947B2Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2013·Granted Jul 15, 2014·5 cites·18 claims
- 2185US7781474B2Inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2007·Granted Aug 24, 2010·7 cites·13 claims
- 2283US9290450B2Compounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2014·Granted Mar 22, 2016·5 cites·27 claims
- 2383US8753679B2Capsule formulation of pirfenidone and pharmaceutically acceptable excipientsINTERMUNE INC·Filed 2013·Granted Jun 17, 2014·4 cites·26 claims
- 2482US10233195B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2015·Granted Mar 19, 2019·4 cites·31 claims
- 2582US7932267B2Use of α-glucosidase inhibitors to treat alphavirus infectionsINTERMUNE INC·Filed 2009·Granted Apr 26, 2011·1 cites·15 claims
- 2681US9561217B2Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridoneINTERMUNE INC·Filed 2015·Granted Feb 7, 2017·2 cites·20 claims
- 2780US10898474B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2019·Granted Jan 26, 2021·1 cites·63 claims
- 2878US8048862B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2009·Granted Nov 1, 2011·3 cites·40 claims
- 2977US9017722B2Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1H)-pyridoneINTERMUNE INC·Filed 2012·Granted Apr 28, 2015·2 cites·14 claims
- 3075US7932277B2Peptide inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2008·Granted Apr 26, 2011·2 cites·79 claims
- 3174US9527816B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2014·Granted Dec 27, 2016·1 cites·24 claims
- 3273US2020038387A1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2019·Application pending·0 cites
- 3371US2019183872A1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2019·Application pending·0 cites
- 3470US2020113884A1Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2019·Application pending·0 cites
- 3570US2019247380A1Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2019·Application pending·0 cites
- 3670US2018311221A1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2018·Application pending·0 cites
- 3769US2019060299A1Pirfenidone Treatment for Patients with Atypical Liver FunctionINTERMUNE INC·Filed 2018·Application pending·0 cites
- 3868US2019000821A1Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2018·Application pending·0 cites
- 3968US2014350060A1Methods of Administering Pirfenidone TherapyINTERMUNE INC·Filed 2014·Application pending·0 cites
- 4068US2018064695A1Methods of administering pirfenidone therapyINTERMUNE INC·Filed 2017·Application pending·0 cites
- 4167US2018140588A1Method of Providing Pirfenidone Therapy to a PatientINTERMUNE INC·Filed 2018·Application pending·0 cites
- 4267US2018200242A1Pirfenidone Treatment for Patients with Atypical Liver FunctionINTERMUNE INC·Filed 2018·Application pending·0 cites
- 4366US2017128429A1Methods of Administering Pirfenidone TherapyINTERMUNE INC·Filed 2017·Application pending·0 cites
- 4465US2015111899A1Pirfenidone therapy and inducers of cytochrome p450INTERMUNE INC·Filed 2014·Application pending·0 cites
- 4565US2017333411A1Pirfenidone treatment for patients with atypical liver functionINTERMUNE INC·Filed 2017·Application pending·0 cites
- 4665US2014073673A1Pirfenidone Treatment for Patients with Atypical Liver FunctionINTERMUNE INC·Filed 2013·Application pending·0 cites
- 4764US2016303098A1Methods of Administering Pirfenidone TherapyINTERMUNE INC·Filed 2016·Application pending·0 cites
- 4864US2013220871A1Method of providing pirfenidone therapy to a patientINTERMUNE INC·Filed 2013·Application pending·0 cites
- 4963US10010536B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2016·Granted Jul 3, 2018·0 cites·4 claims
- 5063USRE39821EManufacture and expression of large structural genesINTERMUNE INC·Filed 2005·Granted Sep 4, 2007·0 cites·3 claims
Showing the top 50 of 105 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →